Cancer News and Research

Latest Cancer News and Research

Live malaria parasites in the skin shut down immune responses and block vaccine function: Study

Why one after another new malaria vaccine tests well in the laboratory but fails in field trials has frustrated legions of malaria researchers, and has been the main stumbling block to malaria eradication. Now, a research team from Germany has unraveled that puzzle and shown that the problem is all about the skin and how it controls the immune system. The implications are profound.

20 May 2010

Mutation in BRCA1 tumor suppressor gene helps develop breast, ovarian cancer: Study

Studies have well established that women who harbor a mutation in the BRCA1 tumor suppressor gene are at greater risk for developing breast and ovarian cancers. Less known is information on other molecular events that may impact cancer formation in cells having a BRCA1 mutation. Investigators from The Cancer Institute of New Jersey and a number of major cancer centers in Europe have identified the role a key protein plays in helping cells with mutant BRCA1 genes to survive.

20 May 2010

Update on Phase I clinical trials of Oncopore for treatment of cancer

The Norwegian pharmaceutical company Lytix Biopharma AS provided an update at the recent BIO conference in Chicago on Phase I clinical trials of Oncopore (LTX-315) for the treatment of cancer.

20 May 2010

Child's autism does not affect family structure

Having a child with autism can put stress on the parents' marriage, and a frequently cited statistic leads to a common perception that the divorce rate among these families is as high as 80 percent. But a study to be released at a news conference today by researchers from Kennedy Krieger Institute in Baltimore found that a child's autism has no effect on the family structure.

20 May 2010

Research shows improved treatment of severe epilepsy reduces overall cost of the condition

Improved treatment of severe epilepsy could reduce the overall cost of the condition, according to research presented at the annual meeting of the International Society of Pharmacoeconomic Outcomes Research at the Hilton Atlanta in Atlanta, Georgia.

20 May 2010

Saint Louis University conducts research to find safe, effective vaccination for dengue

Sponsored by the National Institutes of Health, Saint Louis University's Center for Vaccine Development is conducting research of an investigational vaccine designed to prevent people from contracting dengue, a potentially lethal virus that has rapidly spread around the world.

20 May 2010

Pennsylvania Department of Health recommends hepatitis A and B vaccination for children and adults at risk

The Pennsylvania Department of Health recommends immunization of children and adults at the highest risk for hepatitis during "Hepatitis Awareness Month" and "World Hepatitis Day" on May 19.

20 May 2010

Quest PharmaTech net consolidated loss for 2010 increases to $517,799

Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced financial and operational results for the fiscal year ended January 31, 2010.

20 May 2010

2010 funding program for Inova Life Sciences - George Mason University research collaboration open

What do you get when you mix a world-class health system with an innovative, entrepreneurial university? A very successful research collaboration.

20 May 2010

Wellpoint CEO Braly faces sharp criticism at shareholders meeting

"Pressure is mounting on WellPoint Inc. Chief Executive Angela Braly, who faced tough questions about the health insurer's practices at its annual shareholders meeting Tuesday, before the gathering ended abruptly after a director collapsed," The Wall Street Journal reports.

20 May 2010

EPO rules in favor of Alnylam Pharmaceuticals’ Kreutzer-Limmer '945 patent

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the Board of Appeals of the European Patent Office (EPO) has ruled that claims of the Kreutzer-Limmer '945 (EP 1214945) patent meet needed requirements under European patent law. The '945 patent comprises broad claims covering the length and certain structural requirements for siRNAs that are important for advancement of RNAi therapeutics.

20 May 2010

Over-expression of Stat5 protein leads to deadly spread of prostate cancer: Study

Researchers from the Kimmel Cancer Center at Jefferson have found that Stat5, a signaling protein previously found to be key to survival of prostate cancer, is also involved in metastasis.

20 May 2010

UAMS and partners receive $14.7M NIH grant for extension of biomedical research

Biomedical research in Arkansas has received a $14.7 million boost over five years from the National Institutes of Health (NIH) to continue expanding and improving biomedical research in the state.

20 May 2010

Luminex, HTG launch qBead Gene Expression Assay

Luminex Corporation, the worldwide leader in multiplexed solutions, and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA™), today launched a new custom gene expression product, the qBead Gene Expression Assay (qBead Assay). The companies co-developed the product and have signed an exclusive distribution agreement in which Luminex will begin offering it to the research community.

From Luminex 20 May 2010

Inviragen initiates first clinical trial of DENVax vaccine to protect against dengue fever

Inviragen has announced the initiation of the first clinical trial of its vaccine to protect against dengue fever. The trial, to be conducted at Saint Louis University, is designed to assess the safety of Inviragen's investigational dengue vaccine.

20 May 2010

ImaginAb, GSK CIC conclude two research collaboration agreements

ImaginAb, Inc. and the GSK Clinical Imaging Centre (part of the GlaxoSmithKline Group of Companies) have concluded two research collaboration agreements around a clinical therapeutic antibody asset currently under development by GSK in the field of oncology.

20 May 2010

Phase I study of SNS-032 demonstrates safety, potential clinical activity in treating B-cell malignancies

A Phase I clinical trial of SNS-032, one of the first in a new class of drugs that inhibit cyclin-dependent kinases, demonstrated the drug's safety and potential clinical action against advanced chronic lymphocytic leukemia. Cyclin-dependent kinases are enzymatic proteins that are integrally involved in cellular metabolism, renewal and signaling, and are thought to play key roles in the growth of cancers.

20 May 2010

Curis announces inclusion in NASDAQ Biotechnology Index

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NBI), which will become effective prior to market open on Monday, May 24, 2010.

19 May 2010

Results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 to be presented at ASCO 2010

TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ophthalmology, announced today that results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 will be presented at the annual meeting of the American Society of Clinical Oncology on June 5-7, 2010 in Chicago, IL.

19 May 2010

Medical Properties Trust announces new $450 million credit facility

Medical Properties Trust, Inc. announced today that it has entered into a new $450 million credit facility with a syndicate of banks that replaces the Company's existing $220 million credit facility.

19 May 2010

Cancer News and Research

Latest Cancer News and Research

Live malaria parasites in the skin shut down immune responses and block vaccine function: Study

Mutation in BRCA1 tumor suppressor gene helps develop breast, ovarian cancer: Study

Update on Phase I clinical trials of Oncopore for treatment of cancer

Child's autism does not affect family structure

Research shows improved treatment of severe epilepsy reduces overall cost of the condition

Saint Louis University conducts research to find safe, effective vaccination for dengue

Pennsylvania Department of Health recommends hepatitis A and B vaccination for children and adults at risk

Quest PharmaTech net consolidated loss for 2010 increases to $517,799

2010 funding program for Inova Life Sciences - George Mason University research collaboration open

Wellpoint CEO Braly faces sharp criticism at shareholders meeting

EPO rules in favor of Alnylam Pharmaceuticals’ Kreutzer-Limmer '945 patent

Over-expression of Stat5 protein leads to deadly spread of prostate cancer: Study

UAMS and partners receive $14.7M NIH grant for extension of biomedical research

Luminex, HTG launch qBead Gene Expression Assay

Inviragen initiates first clinical trial of DENVax vaccine to protect against dengue fever

ImaginAb, GSK CIC conclude two research collaboration agreements

Phase I study of SNS-032 demonstrates safety, potential clinical activity in treating B-cell malignancies

Curis announces inclusion in NASDAQ Biotechnology Index

Results from Phase 1 clinical trials of TRC105, TRC102, and TRC093 to be presented at ASCO 2010

Medical Properties Trust announces new $450 million credit facility

Cancer Research - Second Edition eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in